Brilliant Violet 510™ anti-human CD19 Antibody

Pricing & Availability
Clone
HIB19 (See other available formats)
Regulatory Status
RUO
Workshop
V CD19.11
Other Names
B4
Isotype
Mouse IgG1, κ
Ave. Rating
Submit a Review
Product Citations
publications
HIB19_BV510_CD19_Antibody_FC_082512
Human peripheral blood lymphocytes were stained with CD3 APC and CD19 (clone HIB19) Brilliant Violet 510™.
  • HIB19_BV510_CD19_Antibody_FC_082512
    Human peripheral blood lymphocytes were stained with CD3 APC and CD19 (clone HIB19) Brilliant Violet 510™.
See Brilliant Violet 510™ spectral data
Cat # Size Price Quantity Avail. Save
302241 25 tests 132,00€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
302242 100 tests 284,00€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD19 is a 95 kD type I transmembrane glycoprotein also known as B4. It is a member of the immunoglobulin superfamily expressed on B-cells (from pro-B to blastoid B cells, absent on plasma cells) and follicular dendritic cells. CD19 is involved in B cell development, activation, and differentiation. CD19 forms a complex with CD21 (CR2) and CD81 (TAPA-1), and functions as a BCR co-receptor.

Product Details
Technical Data Sheet (pdf)

Product Details

Reactivity
Human, Chimpanzee, Rhesus
Antibody Type
Monoclonal
Host Species
Mouse
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA).
Preparation
The antibody was purified by affinity chromatography and conjugated with Brilliant Violet 510™ under optimal conditions.
Concentration
Lot-specific (please contact technical support for concentration and total µg amount, or use our Lookup tool if you have a lot number.)
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is 5 µl per million cells in 100 µl staining volume or 5 µl per 100 µl of whole blood.

Brilliant Violet 510™ excites at 405 nm and emits at 510 nm. The bandpass filter 510/50 nm is recommended for detection, although filter optimization may be required depending on other fluorophores used. Be sure to verify that your cytometer configuration and software setup are appropriate for detecting this channel. Refer to your instrument manual or manufacturer for support. Brilliant Violet 510™ is a trademark of Sirigen Group Ltd.


Learn more about Brilliant Violet™.

This product is subject to proprietary rights of Sirigen Inc. and is made and sold under license from Sirigen Inc. The purchase of this product conveys to the buyer a non-transferable right to use the purchased product for research purposes only. This product may not be resold or incorporated in any manner into another product for resale. Any use for therapeutics or diagnostics is strictly prohibited. This product is covered by U.S. Patent(s), pending patent applications and foreign equivalents.
Excitation Laser
Violet Laser (405 nm)
Application Notes

Additional reported applications (for the relevant formats) include: immunohistochemical staining of acetone-fixed frozen tissue sections8 and blocking of B cell proliferation. Clone HIB19 is not recommended for formalin-fixed paraffin-embedded sections. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 302267 & 302268).

Application References
  1. Schlossman S, et al. 1995. Leucocyte Typing V. Oxford University Press. New York.
  2. Knapp W, et al. 1989. Leucocyte Typing IV. Oxford University Press. New York.
  3. Bradbury L, et al. 1993. J. Immunol. 151:2915.
  4. Joseph A, et al. 2010. J. Virol. 84:6645. PubMed
  5. Wang X, et al. 2010. Haematologica. 95:884. (FC) PubMed
  6. Walker JD, et al. 2009. J. Immunol. 182:1548. (Block) PubMed
  7. Yoshino N, et al. 2000. Exp. Anim. (Tokyo) 49:97. (FC)
  8. Hansen A, et al. 2002. Arthritis Rheum. 46:2160. (IHC)
  9. Stoeckius M, et al. 2017. Nat. Methods. 14:865. (PG)
  10. Peterson VM, et al. 2017. Nat. Biotechnol. 35:936. (PG)
Product Citations
  1. Rutishauser L, et al. 2017. AIDS Res Hum Retroviruses . 10.1089/AID.2016.0324. PubMed
  2. Martrus G, et al. 2017. PLoS One.. 10.1371/journal.pone.0182532. PubMed
  3. Bradley T et al. 2018. Cell. 175(2):387-399 . PubMed
  4. Lagou V et al. 2018. Cell reports. 25(3):798-810 . PubMed
  5. Sagebiel AF, et al. 2019. Nat Commun. 10:975. PubMed
  6. Baxter AE, et al. 2017. Nat Protoc. 12:2029. PubMed
  7. Ruella M, et al. 2018. Nat Med. 24:1499. PubMed
  8. Shih T, et al. 2019. Front Immunol. 10:1652. PubMed
  9. Abd Hamid M et al. 2019. Cancer Immunol Res. 7(8):1293-1306 . PubMed
  10. Moguche AO et al. 2017. Cell host & microbe. 21(6):695-706 . PubMed
  11. Upasani V, et al. 2019. Front Immunol. 2.152777778. PubMed
  12. Weisberg SP, et al. 2020. Cell Reports. 29(12):3916-3932.e5.. PubMed
  13. Catapano M, et al. 2020. J Invest Dermatol. 140:816. PubMed
  14. Krummey SM, et al. 2020. Cell Reports. 30(5):1282-1291.e5.. PubMed
  15. Giron LB, et al. 2020. EBioMedicine. 73.94791667. PubMed
  16. Pucino V, et al. 2020. Cell Metabolism. 30(6):1055-1074.e8.. PubMed
  17. Morris AB, et al. 2020. Immunity. 52(1):136-150.e6.. PubMed
  18. Sekine T, et al. 2020. Cell. 183:158. PubMed
  19. Sung JA, et al. 2018. Mol Ther. 26:2496. PubMed
  20. Demers K, et al. 2016. PLoS Pathog. 12: 1005805. PubMed
  21. Mackroth M, et al. 2016. PLoS Pathog. 12:e1005909. PubMed
  22. Rakshit S, et al. 2020. Cell Rep. 33:108451. PubMed
  23. Bäcker-Koduah P, et al. 2020. Ann Clin Transl Neurol. 1.422222222. PubMed
  24. Danzer H, et al. 2020. Elife. 9:00. PubMed
  25. Hu EY, et al. 2020. JCI Insight. 5:00. PubMed
  26. Eslamizar L, et al. 2021. NPJ Vaccines. 6:15. PubMed
  27. Buggert M, et al. 2020. Cell. 183(7):1946-1961.e15. PubMed
  28. Bonifacius A, et al. 2021. Immunity. 54(2):340-354.e6. PubMed
  29. Caduff N, et al. 2021. Cell Reports. 35(5):109056. PubMed
RRID
AB_2561381 (BioLegend Cat. No. 302241)
AB_2561668 (BioLegend Cat. No. 302242)

Antigen Details

Structure
Ig superfamily, type I transmembrane glycoprotein, 95 kD
Distribution

B lineage (except plasma cells), follicular dendritic cells

Function
B cell activation and differentiation
Ligand/Receptor
Forms complex with CD21 (CR2) and CD81 (TAPA-1), BCR coreceptor
Cell Type
B cells, Dendritic cells
Biology Area
Costimulatory Molecules, Immunology
Molecular Family
CD Molecules
Antigen References

1. Tedder T, et al. 1994. Immunol. Today 15:437.
2. Bradbury L, et al. 1993. J. Immunol. 151:2915.

Gene ID
930 View all products for this Gene ID
UniProt
View information about CD19 on UniProt.org

Related FAQs

There are no FAQs for this product.

Other Formats

View All CD19 Reagents Request Custom Conjugation
Description Clone Applications
APC anti-human CD19 HIB19 FC
Biotin anti-human CD19 HIB19 FC
FITC anti-human CD19 HIB19 FC
PE anti-human CD19 HIB19 FC
PE/Cyanine5 anti-human CD19 HIB19 FC
Purified anti-human CD19 HIB19 FC, CyTOF®, IHC-F
Brilliant Violet 421™ anti-human CD19 HIB19 FC, ICC, IHC-F
APC/Fire™ 750 anti-human CD19 HIB19 FC
Pacific Blue™ anti-human CD19 HIB19 FC
APC/Cyanine7 anti-human CD19 HIB19 FC
PE/Cyanine7 anti-human CD19 HIB19 FC
APC anti-human CD19 HIB19 FC
TotalSeq™-A0050 anti-human CD19 HIB19 PG
PerCP/Cyanine5.5 anti-human CD19 HIB19 FC
Ultra-LEAF™ Purified anti-human CD19 HIB19 FC, CyTOF®, Block, IHC
Alexa Fluor® 488 anti-human CD19 HIB19 FC, ICC
Alexa Fluor® 647 anti-human CD19 HIB19 FC, IHC-F
Pacific Blue™ anti-human CD19 HIB19 FC
APC/Fire™ 810 anti-human CD19 HIB19 FC
Alexa Fluor® 700 anti-human CD19 HIB19 FC
PerCP anti-human CD19 HIB19 FC
PerCP/Cyanine5.5 anti-human CD19 HIB19 FC
Brilliant Violet 650™ anti-human CD19 HIB19 FC
TotalSeq™-B0050 anti-human CD19 HIB19 PG
TotalSeq™-C0050 anti-human CD19 HIB19 PG
Brilliant Violet 785™ anti-human CD19 HIB19 FC
Purified anti-human CD19 (Maxpar® Ready) HIB19 FC, CyTOF®
PE/Dazzle™ 594 anti-human CD19 HIB19 FC
PE/Fire™ 700 anti-human CD19 HIB19 FC
PE/Fire™ 640 anti-human CD19 HIB19 FC
Brilliant Violet 605™ anti-human CD19 HIB19 FC
Brilliant Violet 711™ anti-human CD19 HIB19 FC
PE anti-human CD19 HIB19 FC
Spark NIR™ 685 anti-human CD19 HIB19 FC
Brilliant Violet 570™ anti-human CD19 HIB19 FC
PE/Cyanine7 anti-human CD19 HIB19 FC
Alexa Fluor® 594 anti-human CD19 HIB19 ICC, IHC-F
TotalSeq™-D0050 anti-human CD19 HIB19 PG
Brilliant Violet 750™ anti-human CD19 HIB19 FC
Spark YG™ 593 anti-human CD19 HIB19 FC
GMP Pacific Blue™ anti-human CD19 HIB19 FC
Go To Top Version: 2    Revision Date: 12-18-2013

For research use only. Not for diagnostic use. Not for resale. BioLegend will not be held responsible for patent infringement or other violations that may occur with the use of our products.

 

*These products may be covered by one or more Limited Use Label Licenses (see the BioLegend Catalog or our website, www.biolegend.com/ordering#license). BioLegend products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products, reverse engineer functionally similar materials, or to provide a service to third parties without written approval of BioLegend. By use of these products you accept the terms and conditions of all applicable Limited Use Label Licenses. Unless otherwise indicated, these products are for research use only and are not intended for human or animal diagnostic, therapeutic or commercial use.

 

BioLegend Inc., 8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

  • APC anti-human CD19

  • Biotin anti-human CD19

  • FITC anti-human CD19

  • PE anti-human CD19

  • PE/Cyanine5 anti-human CD19

  • Purified anti-human CD19

  • Brilliant Violet 421™ anti-human CD19

  • APC/Fire™ 750 anti-human CD19

  • Pacific Blue™ anti-human CD19

  • APC/Cyanine7 anti-human CD19

  • PE/Cyanine7 anti-human CD19

  • APC anti-human CD19

  • TotalSeq™-A0050 anti-human CD19

  • PerCP/Cyanine5.5 anti-human CD19

  • Ultra-LEAF™ Purified anti-human CD19

  • Alexa Fluor® 488 anti-human CD19

  • Alexa Fluor® 647 anti-human CD19

  • Pacific Blue™ anti-human CD19

  • APC/Fire™ 810 anti-human CD19

  • Alexa Fluor® 700 anti-human CD19

  • PerCP anti-human CD19

  • PerCP/Cyanine5.5 anti-human CD19

  • Brilliant Violet 650™ anti-human CD19

  • TotalSeq™-B0050 anti-human CD19

  • TotalSeq™-C0050 anti-human CD19

  • Brilliant Violet 785™ anti-human CD19

  • Purified anti-human CD19 (Maxpar® Ready)

  • PE/Dazzle™ 594 anti-human CD19

  • PE/Fire™ 700 anti-human CD19

  • PE/Fire™ 640 anti-human CD19

  • Brilliant Violet 605™ anti-human CD19

  • Brilliant Violet 711™ anti-human CD19

  • PE anti-human CD19

  • Spark NIR™ 685 anti-human CD19

  • Brilliant Violet 570™ anti-human CD19

  • PE/Cyanine7 anti-human CD19

  • Alexa Fluor® 594 anti-human CD19

  • TotalSeq™-D0050 anti-human CD19

  • Brilliant Violet 750™ anti-human CD19

  • Spark YG™ 593 anti-human CD19

  • GMP Pacific Blue™ anti-human CD19

ProductsHere
Insert Note Here
Save Close Clear
Lab Timer
Tools
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account